Lisanti Capital Growth, LLC Horizon Therapeutics Public LTD CO Transaction History

Lisanti Capital Growth, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$79.4 - $116.36 $3.03 Million - $4.44 Million	-38,115 Reduced 43.55%	49,397 $3.94 Million
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $5.17 Million - $6.57 Million	59,827 Added 216.1%	87,512 $9.21 Million
Q4 2021 Feb 04, 2022	SELL	$98.56 - $119.91 $94,617 - $115,113	-960 Reduced 3.35%	27,685 $2.98 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $1.7 Million - $1.89 Million	-19,755 Reduced 40.82%	28,645 $2.68 Million
Q1 2021 May 12, 2021	BUY	$71.83 - $95.48 $1.72 Million - $2.29 Million	24,005 Added 98.4%	48,400 $4.46 Million
Q4 2020 Feb 10, 2021	SELL	$67.0 - $84.39 $838,840 - $1.06 Million	-12,520 Reduced 33.92%	24,395 $1.78 Million
Q3 2020 Nov 05, 2020	SELL	$55.23 - $79.93 $4.77 Million - $6.9 Million	-86,290 Reduced 70.04%	36,915 $2.87 Million
Q2 2020 Aug 10, 2020	SELL	$30.2 - $56.98 $3.43 Million - $6.46 Million	-113,448 Reduced 47.94%	123,205 $6.85 Million
Q1 2020 May 11, 2020	SELL	$24.87 - $38.56 $681,189 - $1.06 Million	-27,390 Reduced 10.37%	236,653 $7.01 Million
Q4 2019 Feb 13, 2020	BUY	$25.43 - $36.67 $767,426 - $1.11 Million	30,178 Added 12.9%	264,043 $9.56 Million
Q3 2019 Nov 06, 2019	BUY	$23.0 - $27.97 $630,085 - $766,238	27,395 Added 13.27%	233,865 $6.37 Million
Q2 2019 Aug 05, 2019	BUY	$22.81 - $28.48 $4.71 Million - $5.88 Million	206,470 New	206,470 $4.97 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.